The Institute of Cancer Research

The Institute of Cancer Research The ICR is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.

Our mission is to make the discoveries that defeat cancer. The Institute of Cancer Research is making the discoveries that defeat cancer. In addition to being a leading cancer research organisation, we are also a postgraduate college (a member of the University of London), as well as a charity. To make a donation to support our work please visit icr.ac.uk/donate

🚨Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS that cuts treatment time...
10/06/2026

🚨Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS that cuts treatment time by up to 75%.

Stereotactic body radiotherapy (SBRT) delivers higher radiation doses in fewer sessions, reducing side effects and the risk of tumour growth or spread.

Researchers from the ICR and The Royal Marsden NHS led the PACE-B trial that showed that these 5 high doses of radiation, given over one to two weeks, are just as effective as the standard radiotherapy – more moderate doses given over around 20 sessions.

The treatment will now be available on the NHS for men with low or intermediate risk prostate cancer. Trials are underway to test the treatment for men with high-risk disease.

09/06/2026

Are you really giving cancer herpes? 🤔

🎙️ Professor Kevin Harrington spoke to Naga Munchetty and Chris Smith ( )on

He spoke about how the early discoveries were made that viruses could infect tumours, and how this has led to modern, genetically engineered viruses to treat cancer - called oncolytic virotherapy.

“Research has been absolutely crucial in keeping me alive”  In December 2014, shortly before his 32nd birthday, Mo Haque...
04/06/2026

“Research has been absolutely crucial in keeping me alive”

In December 2014, shortly before his 32nd birthday, Mo Haque was diagnosed with stage 4 inoperable bowel cancer. He was told there was only a small chance he could be treated successfully. However, thanks to immunotherapy, he has had no evidence of disease since 2018.

“When the oncologist told me my cancer was stage 4, inoperable, and that there was only a small chance of treating it successfully, it was very hard to hear. At this point, the picture seemed very bleak to me. I was devastated.”

Mo initially had chemotherapy, followed by surgery and then more chemo. But his cancer continued to grow, and he was told it was terminal.

Following his diagnosis, Mo also learned he had Lynch syndrome, a genetic condition which makes him more pre-disposed to certain types of cancer. His oncologist suggested that this would make him a good candidate for immunotherapy.

He started immunotherapy in 2016 and two years later, he was told there was no evidence of disease in his body. Ten years on, he’s making the most of life.

“I am very aware that I have benefitted from previous immunotherapy research. If it was not for the scientists and researchers who are continually plugging away, the immunotherapy drug I took might not have been available to me.

“These days, when I go for a run in my Saturday morning running club, no one would even know I had cancer. I feel like I can start the next chapter of my life and look ahead to plenty of good things to come.”

Mo is sharing his story as part of our appeal to give everyone with bowel cancer the hope of a cure.

Read his story here ⬇
www.icr.ac.uk/research-and-discoveries/cancer-blogs/detail/science-talk/research-has-been-absolutely-crucial-in-keeping-me-alive----mo-s-bowel-cancer-story

❤ “It is progress that gives cancer patients hope”  Martin Newman, 79, was diagnosed with an aggressive form of prostate...
02/06/2026

❤ “It is progress that gives cancer patients hope”

Martin Newman, 79, was diagnosed with an aggressive form of prostate cancer in 2023.

Fortunately, it was caught early and after nine months of treatment, including hormone injections and laser therapy, he was told he was in remission.

A keen cyclist since his teenage years, Martin wanted to prove to himself he could still do it with a 3,500km solo cycle-ride around Italy’s coast.

He completed his adventure last April and has since written a book about it, with the sale proceeds going towards our groundbreaking research.

“My diagnosis was a complete shock and came after several painful years during which my wife, Jenny, had undergone treatment for bowel cancer. Doctors had said her prospects weren’t good, but remarkably she defied the odds and made a full recovery.

“I have so much gratitude for the treatment we both received.

“We are fighting a war against cancer, and this is gradually being won thanks to the wonderful work being done by researchers and medics. Cancer research is vital going forward – it is progress that gives patients like me hope.”

Martin’s book is available to buy now. You can read his story and purchase your copy here ⬇
My Giro: A Journey of Recovery and Discovery - https://www.amazon.com/My-Giro-journey-recovery-discovery-ebook/dp/B0FRY49PZ7

"Our mission is to change the odds for other families"Jessica Brown was nine when she died from medulloblastoma, a fast-...
01/06/2026

"Our mission is to change the odds for other families"

Jessica Brown was nine when she died from medulloblastoma, a fast-growing brain tumour, in March 2024.

Her parents say she was brave, kind and generous, always wanting to make others feel better. After her death, her desire to improve the lives of others inspired them to donate her brain tissue to our research.

They have since set up Jessie’s Argonauts , a charity to honour her memory, with the mission of supporting research into kinder, more effective treatments — so other children facing a similar devastating diagnosis will be able to enjoy the future Jessie was unable to have.

The charity has recently donated £5,000 to support our research into new targeted treatments for medulloblastoma.

Sally, Jessie’s mum, says: "To go through all this grief and pain and then try to walk away from the situation, knowing the next child who relapses will have the same thing happen, seems wrong and makes our child's death seem senseless.

We want something good to come out of the bad, to change the odds for other families, and we know Jessie would have wanted this too. It would be lovely if the research we are supporting could lead to a potential new treatment that could be taken to clinical trial."

✨ ❤️ We are delighted to welcome Jessie’s Argonauts as one of our new charity partners and are extremely grateful to the Brown family for supporting our childhood brain cancer research.

🚨A new study has found that a targeted cancer treatment given as a simple injection under the skin could help patients w...
31/05/2026

🚨A new study has found that a targeted cancer treatment given as a simple injection under the skin could help patients with advanced head and neck cancer who have limited treatment options.

ICR researchers reported that tumours shrank in 42% of patients whose cancer had stopped responding to standard treatments.

The drug, amivantamab, is also quicker and easier to give than many existing treatments.

While larger trials are still needed, the findings offer encouraging early evidence of a potential new option for patients.

Find out more⬇
https://www.icr.ac.uk/about-us/icr-news/detail/immunotherapy-injection-shrinks-tumours-in-patients-with-head-and-neck-cancer

29/05/2026

We’re back with another 20 second challenge for Dr Pebs Edwards ⏱️

Our researchers and scientists are always working on making new discoveries so we ask “what is the most exciting thing you are working on at the moment?”

Can Dr Edwards beat the clock?

Learn more about our Boomers project via the link in our bio 🔗

28/05/2026

🎥: We caught up with some of our speakers from this year’s events.

We asked Owen White, Dr Shefali Thakur, Dr Matthew Jessop, and Dr Nefeli Skoufou Papoutsaki to share a snippet of their topics, and and why it’s so important to share what we do at the ICR with the public.

Don’t worry if you missed this year’s events, we’ll be back next year with even more for curious minds! 🧠 🧬 🔬

Earlier this month, we were delighted to welcome ICR’s legacy supporters to our Chelsea site for a special afternoon tea...
27/05/2026

Earlier this month, we were delighted to welcome ICR’s legacy supporters to our Chelsea site for a special afternoon tea.

🔬🧫🧬 Guests heard from our scientists, toured our labs, met members of the team, and learned more about the impact that legacy gifts make to our research and patients.

❤️ A heartfelt thank you to those who have chosen to leave a gift in their Will to the ICR.

Your support is helping to fund our life-saving research and give countless people hope for the future.

If you are interested in learning how you can make a difference, you can order a free legacy guide here ⬇
https://www.icr.ac.uk/order-a-legacy-guide

26/05/2026

📽️: a round up of our Pint of Science sessions in 30 seconds!

A huge thank you to everyone who came along to our events in Chelsea and Sutton 🙏❤️

If you missed out this year, don’t worry! We will back next year with more weird and wonderful topics 🥼🧪🧫

Address

London

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+442073528133

Alerts

Be the first to know and let us send you an email when The Institute of Cancer Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organisation

Send a message to The Institute of Cancer Research:

Share